I. Neb

发表

Genome-wide association study in European patients with congenital heart disease identifies risk loci for transposition of the great arteries and anomalies of the thoracic arteries and veins and expression of discovered candidate genes in the developing heart

R. Lange, J. Priest, T. Meitinger, 2020, bioRxiv.

Myosin binding protein H-like (MYBPHL): a promising biomarker to predict atrial damage

R. Lange, M. Mann, M. Deutsch, 2019, Scientific Reports.

Myosin binding protein H-like (MYBPHL)

M. Deutsch, M. Krane, M. Mann, 2019 .

Uncovering the molecular identity of cardiosphere-derived cells (CDCs) by single-cell RNA sequencing

M. Krane, L. Holdt, A. Tomar, 2022, Basic Research in Cardiology.

miR-128a Acts as a Regulator in Cardiac Development by Modulating Differentiation of Cardiac Progenitor Cell Populations

R. Lange, J. Erdmann, H. Schunkert, 2020, International journal of molecular sciences.

Congenital heart disease risk loci identified by genome-wide association study in European patients.

R. Lange, J. Priest, T. Meitinger, 2020, The Journal of clinical investigation.

Sequential Defects in Cardiac Lineage Commitment and Maturation Cause Hypoplastic Left Heart Syndrome

R. Lange, M. Mann, T. Meitinger, 2021, bioRxiv.

Generation of three CRISPR/Cas9 edited human induced pluripotent stem cell lines (DHMi005-A-5, DHMi005-A-6 and DHMi005-A-7) carrying a Holt-Oram Syndrome patient-specific TBX5 mutation with known cardiac phenotype and a FLAG-tag after exon 9 of the TBX5 gene.

H. Lahm, S. Doppler, M. Dreßen, 2023, Stem cell research.

Correction of a deleterious TBX5 mutation in an induced pluripotent stem cell line (DHMi004-A-1) using a completely plasmid-free CRISPR/Cas 9 approach.

M. Krane, H. Lahm, S. Doppler, 2023, Stem cell research.

Generation of two CRISPR/Cas edited human induced pluripotent stem cell lines (DHMi005-A-3 and DHMi005-A-4) carrying a FLAG-tag after exon 9 of the TBX5 gene.

H. Lahm, S. Doppler, M. Dreßen, 2022, Stem cell research.

Establishment of an induced pluripotent stem cell line DHMi005-A from a healthy male proband.

H. Lahm, S. Doppler, M. Dreßen, 2022, Stem cell research.

Generation of a CRISPR/Cas edited human induced pluripotent stem cell line DHMi005-A-1 carrying a patient-specific disease-causing point mutation in the TBX5 gene.

M. Krane, P. Heinrich, H. Lahm, 2022, Stem cell research.

Establishment of a patient-specific induced pluripotent stem cell line DHMi004-A from a male Holt-Oram syndrome patient with verified TBX5 mutation.

H. Lahm, S. Doppler, M. Dreßen, 2021, Stem cell research.